COMMUNIQUÉS West-GlobeNewswire

-
Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange
04/06/2024 -
Dr. John Q. Cook of the Whole Beauty® Institute Chicago to Present at the International Society of Aesthetic Plastic Surgery World Congress
04/06/2024 -
Physicians’ Right to Free Speech Upheld in AAPS v. ABIM
04/06/2024 -
Nordic Naturals Joins 40th Annual California Coastal Cleanup to Protect the Health of the Oceans
04/06/2024 -
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
04/06/2024 -
18 Genesis HealthCare Affiliated Centers Earn 2024 AHCA/NCAL Bronze National Quality Award
04/06/2024 -
TytoCare Introduces Major Release to Increase Flexibility and Accessibility of Care Delivery
04/06/2024 -
Floré Clinical Teams Up with Evexia Diagnostics to Distribute Personalized Microbiome Mapping Technology to 20,000 Clinicians
04/06/2024 -
Vilya Expands Series A Financing to $71 Million to Advance Computational Drug Design and Develop a New Class of Medicines
04/06/2024 -
Raydiant Oximetry Oversubscribes Series A $7.5 Million Extension Round
04/06/2024 -
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
04/06/2024 -
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
04/06/2024 -
Deep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients
04/06/2024 -
Aviv Clinics Announces Case Study Showing Benefits of Hyperbaric Oxygen Therapy for Military Post-Traumatic Stress Disorder in Elderly Veterans
04/06/2024 -
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
04/06/2024 -
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
04/06/2024 -
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
04/06/2024 -
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
04/06/2024 -
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
04/06/2024
Pages